ArticleSmall science2024
Nanocomposite Hydrogel-Based Optical Fiber Probe for Continuous Glucose Sensing.
Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Recent Advances in Nanocomposite Hydrogel Sensors for Healthcare Applications: Fabrication Techniques, Multifunctionality and Challenges.Nanomaterials (Basel, Switzerland) · 2026Review
- Emerging trends in 2D nanostructured electrode materials as enzyme-mimicking glucose sensors for biomedical diagnostics: a comprehensive review.Mikrochimica acta · 2025Review
- Hydrogel-Based Treatment of Diabetic Wounds: From Smart Responsive to Smart Monitoring.Gels (Basel, Switzerland) · 2025Review
- Ophthalmic Tethered Gold Yarnball-Mediated Retained Drug Delivery for Eye Fundus Disease Treatment.Small science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus (DM) presents a substantial global health concern due to elevated blood glucose levels, necessitating an affordable, rapid, and reliable continuous glucose monitoring (CGM) solution. In this pursuit, a pioneering approach is introduced utilizing optical fiber (OF) sensors based on nanocomposite photonic hydrogel functionalized with phenylboronic acid (PBA) for precise CGM. The fabrication of OF sensors involves a streamlined process, involving one-step polymerization of PBA-based hydrogel onto a commercial fiber tip and the integration of gold nanoparticles (AuNPs) via a simple dipping process. These sensors offer robust performance within the physiological glucose range (0-20 mm), exhibiting a remarkable 25% increase in transmission intensity and a 4 nm blue shift in the surface plasmon resonance with increasing glucose concentration. Additionally, there is a noticeable elevation in reflection intensity, affirming the sensor's suitability for remote sensing applications. These results are further validated using a green laser, underlining the method's reliability. The sensors exhibit a swift 30 s response time, followed by a 5 min saturation period, for all measurements. Practicality is demonstrated through smartphone readouts, utilizing the phone's photodiode to measure optical power changes concerning various glucose concentrations. These OF sensors hold great promise for CGM integration, enhancing diabetic management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.